Pharmaceutical Technology, Oct 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Oct 1, 2010
Featured Content
Quantitative Open-Access HPLC Analysis
By Phil Borman , John Roberts , Barbara O'Reilly , Robin Attrill , Ian Barylski , Keith Freebairn
The authors discuss the approach taken to develop a new calibration approach, its associated protocols, and how it can be used to calculate data.
Investigating the Influence of Glycosylation on Protein Conformation and Dynamics
By Damian Houde , Steven A. Berkowitz
The authors review and discuss the influence of glycans on the conformation of a representative IgG1 biopharmceutical using H/DX-MS as an analytical tool.
Process Analytical Technology-Based In-Line Buffer Dilution In Downstream Bioprocessing
By Michael Li , Vivek Kamat , Hiroyuki Yabe , Shree Jariwala , Tomo Miyabayashi
The authors describe the operational requirements and design of a process-ready PAT-based IBD system.
The Elements of an Effective Solid-Dosage Metal Detection Program
By Bob Ries
The author discusses new detection-system technologies that can improve performance and provides key criteria to consider when selecting or upgrading a system for pharmaceutical use.
Small-Angle X-ray Scattering for Pharmaceutical Applications
By Gerd Langenbucher
The author describes the development of small-angle X-ray scattering and analyzes its advantages in the characterization of drug-delivery systems and large molecules. This article is part of a special Analytical Technology issue.
Analytical Applications
By Jonathan Yourkin , Lori Daane , Judy Madden , Simon Robinson , Kevin Menard
Several industry experts describe applications in pharmaceutical applications, including on-line total organic carbon analysis, ultra-fast liquid chromatography, rapid microbial testing, and differential scanning calorimetry-Raman Spectroscopy.
Crucial Considerations in Monitoring Process Performance and Product Quality
By Ronald D. Snee
The author outlines key considerations for carrying out a structured approach to monitoring process performance and ensuring product quality.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here